<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36906866</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-160X</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study.</ArticleTitle><Pagination><StartPage>1485</StartPage><EndPage>1495</EndPage><MedlinePgn>1485-1495</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-023-05300-x</ELocationID><Abstract><AbstractText>Pediatric mixed connective tissue disease (MCTD) is a subgroup of overlap syndromes. We aimed to compare the characteristics and outcomes in children with MCTD and other overlap syndromes. All MCTD patients met either Kasukawa or Alarcon-Segovia and Villareal criteria. The patients with other overlap syndromes had the features of&#x2009;&#x2265;&#x2009;2 autoimmune rheumatic diseases but did not meet MCTD diagnostic criteria. Thirty MCTD (F/M&#x2009;=&#x2009;28/2) and thirty (F/M&#x2009;=&#x2009;29/1) overlap patients were included (disease onset&#x2009;&lt;&#x2009;18&#xa0;years). The most prominent phenotype at disease onset and the last visit was systemic lupus erythematosus (SLE) in the MCTD group; juvenile idiopathic arthritis and dermatomyositis/polymyositis, respectively, in the overlap group. At the last visit, systemic sclerosis (SSc) phenotype was more frequent among MCTD than overlap patients (60% vs. 33.3%; p&#x2009;=&#x2009;0.038). The frequency of the predominant SLE phenotype had decreased (60% to 36.7%), while predominant SSc phenotype had increased (13.3% to 33.3%) during follow-up in MCTD patients. Weight loss (36.7% vs. 13.3%), digital ulcers (20% vs. 0), swollen hands (60% vs. 20%), Raynaud phenomenon (86.7% vs. 46.7%), hematologic involvement (70% vs. 26.7%), and anti-Sm positivity (29% vs. 3.3%) were more common, while Gottron papules (16.7% vs. 40%) were less frequent among MCTD than overlap patients (p&#x2009;&lt;&#x2009;0.05). A higher percentage of overlap patients achieved complete remission than MCTD patients (51.7% vs. 24.1%; p&#x2009;=&#x2009;0.047). The disease phenotype and outcome differ between pediatric MCTD and other overlap syndromes where MCTD may be regarded as a more severe disease. Analyzing these patients could pave the way for early and effective treatment.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Batu</LastName><ForeName>Ezgi Deniz</ForeName><Initials>ED</Initials><Identifier Source="ORCID">0000-0003-1065-2363</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey. ezgidenizbatu@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>&#xc7;ocuk Romatoloji B&#xf6;l&#xfc;m&#xfc;, Hacettepe &#xdc;niversitesi &#x130;hsan Do&#x11f;ramac&#x131; &#xc7;ocuk Hastanesi, Kat: 3 S&#x131;hhiye, 06100, Ankara, Turkey. ezgidenizbatu@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nalp</LastName><ForeName>Ayb&#xfc;ke</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0137-0460</Identifier><AffiliationInfo><Affiliation>Cerrahpasa Medical School, Department of Pediatrics, Division of Rheumatology, Istanbul University Cerrahpasa, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x15e;ahin</LastName><ForeName>Sezgin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5365-3457</Identifier><AffiliationInfo><Affiliation>Cerrahpasa Medical School, Department of Pediatrics, Division of Rheumatology, Istanbul University Cerrahpasa, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zdel</LastName><ForeName>Semanur</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5602-4595</Identifier><AffiliationInfo><Affiliation>Dr. Sami Ulus Maternity and Child Health and Diseases Research and Training Hospital, Department of Pediatrics, Division of Rheumatology, University of Health Sciences, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#x131;z&#x131;lda&#x11f;</LastName><ForeName>Zehra</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-7938-2560</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Rheumatology, Dokuz Eyl&#xfc;l University Faculty of Medicine, Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pac K&#x131;saarslan</LastName><ForeName>Aysenur</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1800-9922</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Pediatrics, Division of Rheumatology, Erciyes University, Kayseri, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba&#x11f;rul</LastName><ForeName>&#x130;lknur</ForeName><Initials>&#x130;</Initials><Identifier Source="ORCID">0000-0002-5585-0198</Identifier><AffiliationInfo><Affiliation>Dr. Sami Ulus Maternity and Child Health and Diseases Research and Training Hospital, Department of Pediatrics, Division of Rheumatology, University of Health Sciences, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasap Cuceoglu</LastName><ForeName>Muserref</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9957-8894</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanatar</LastName><ForeName>Ay&#x15f;e</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1386-4575</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Pediatrics, Division of Rheumatology, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonmez</LastName><ForeName>Hafize Emine</ForeName><Initials>HE</Initials><Identifier Source="ORCID">0000-0002-9186-3068</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Pediatrics, Division of Rheumatology, Kocaeli University, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sag</LastName><ForeName>Erdal</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6542-2656</Identifier><AffiliationInfo><Affiliation>Ankara Research and Training Hospital, Department of Pediatrics, Division of Rheumatology, University of Health Sciences, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demir</LastName><ForeName>Selcan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4320-8632</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Rheumatology, Erzurum Regional Research and Training Hospital, Erzurum, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;elikel</LastName><ForeName>Elif</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0129-4410</Identifier><AffiliationInfo><Affiliation>Ankara City Hospital, Department of Pediatrics, Division of Rheumatology, University of Health Sciences, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ca&#x11f;layan</LastName><ForeName>Sengul</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3014-5692</Identifier><AffiliationInfo><Affiliation>Umraniye Research and Training Hospital, Department of Pediatrics, Division of Rheumatology, University of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;elikel Acar</LastName><ForeName>Banu</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-1808-3655</Identifier><AffiliationInfo><Affiliation>Ankara City Hospital, Department of Pediatrics, Division of Rheumatology, University of Health Sciences, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf6;zeri</LastName><ForeName>Bet&#xfc;l</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5079-5644</Identifier><AffiliationInfo><Affiliation>Umraniye Research and Training Hospital, Department of Pediatrics, Division of Rheumatology, University of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aktay Ayaz</LastName><ForeName>Nuray</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-3594-7387</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Pediatrics, Division of Rheumatology, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilginer</LastName><ForeName>Yelda</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6232-0072</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poyrazo&#x11f;lu</LastName><ForeName>M Hakan</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0002-5142-8432</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Pediatrics, Division of Rheumatology, Erciyes University, Kayseri, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xdc;nsal</LastName><ForeName>Erbil</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8800-0800</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Rheumatology, Dokuz Eyl&#xfc;l University Faculty of Medicine, Izmir, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasap&#xe7;opur</LastName><ForeName>&#xd6;zg&#xfc;r</ForeName><Initials>&#xd6;</Initials><Identifier Source="ORCID">0000-0002-1125-7720</Identifier><AffiliationInfo><Affiliation>Cerrahpasa Medical School, Department of Pediatrics, Division of Rheumatology, Istanbul University Cerrahpasa, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zen</LastName><ForeName>Seza</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2883-7868</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000721267">digital ulcers</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008947" MajorTopicYN="Y">Mixed Connective Tissue Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003240" MajorTopicYN="Y">Connective Tissue Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012595" MajorTopicYN="Y">Scleroderma, Systemic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adolescent</Keyword><Keyword MajorTopicYN="N">Autoimmune diseases</Keyword><Keyword MajorTopicYN="N">Child</Keyword><Keyword MajorTopicYN="N">Mixed connective tissue disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>12</Day><Hour>14</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36906866</ArticleId><ArticleId IdType="doi">10.1007/s00296-023-05300-x</ArticleId><ArticleId IdType="pii">10.1007/s00296-023-05300-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berard RA, Laxer RM (2016) Pediatric mixed connective tissue disease. Curr Rheumatol Rep 18:28. https://doi.org/10.1007/s11926-016-0576-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-016-0576-x</ArticleId><ArticleId IdType="pubmed">27032791</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungprasert P, Crowson CS, Chowdhary VR, Ernste FC, Moder KG, Matteson EL (2016) Epidemiology of mixed connective tissue disease, 1985&#x2013;2014: a population-based study. Arthritis Care Res 68:1843&#x2013;1848. https://doi.org/10.1002/acr.22872</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22872</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 42:899&#x2013;909. https://doi.org/10.1002/1529-0131(199905)42:5%3c899::AID-ANR8%3e3.0.CO;2-L</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199905)42:5&lt;899::AID-ANR8&gt;3.0.CO;2-L</ArticleId><ArticleId IdType="pubmed">10323445</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotajima L, Aotsuka S, Sumiya M, Yokohari R, Tojo T, Kasukawa R (1996) Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan. J Rheumatol 23:1088&#x2013;1094</Citation><ArticleIdList><ArticleId IdType="pubmed">8782145</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappelli S, Bellando Randone S, Martinovic D, Tamas MM, Pasalic K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radic M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirjak L, Damjanov N, Rednic S, MatucciCerinic M (2012) &#x201c;To be or not to be,&#x201d; ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum 41:589&#x2013;598. https://doi.org/10.1016/j.semarthrit.2011.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2011.07.010</ArticleId><ArticleId IdType="pubmed">21959290</ArticleId></ArticleIdList></Reference><Reference><Citation>Michels H (1997) Course of mixed connective tissue disease in children. Ann Med 29:359&#x2013;364. https://doi.org/10.3109/07853899708999362</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853899708999362</ArticleId><ArticleId IdType="pubmed">9453280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetlevik SO, Flato B, Rygg M, Nordal EB, Brunborg C, Hetland H, Lilleby V (2017) Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study. Ann Rheum Dis 76:159&#x2013;165. https://doi.org/10.1136/annrheumdis-2016-209522</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2016-209522</ArticleId><ArticleId IdType="pubmed">27283334</ArticleId></ArticleIdList></Reference><Reference><Citation>Mier RJ, Shishov M, Higgins GC, Rennebohm RM, Wortmann DW, Jerath R, Alhumoud E (2005) Pediatric-onset mixed connective tissue disease. Rheum Dis Clin North Am 31(483&#x2013;496):vii. https://doi.org/10.1016/j.rdc.2005.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2005.04.002</ArticleId><ArticleId IdType="pubmed">16084320</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkowska-Sak L, Gietka P (2019) Clinical features and outcome of mixed connective tissue disease in developmental age&#x2014;observational study from one center. Reumatologia 57:315&#x2013;319. https://doi.org/10.5114/reum.2019.91275</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/reum.2019.91275</ArticleId><ArticleId IdType="pubmed">32226164</ArticleId><ArticleId IdType="pmc">7091480</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasukawa R, Tojo T, Miyawaki S (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and antinuclear antibodies. Elsevier Science Publishers BV (Biomedical Division), Amsterdam, pp 41&#x2013;47</Citation></Reference><Reference><Citation>Alarc&#xf3;n-Segovia D, Villareal M (1987) Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and antinuclear antibodies. Elsevier Science Publishers BV (Biomedical Division), Amsterdam, pp 33&#x2013;40</Citation></Reference><Reference><Citation>Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677&#x2013;2686. https://doi.org/10.1002/art.34473</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId><ArticleId IdType="pmc">3409311</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberal R, Vergani D, Mieli-Vergani G (2015) Update on autoimmune hepatitis. J Clin Transl Hepatol 3:42&#x2013;52. https://doi.org/10.14218/JCTH.2014.00032</Citation><ArticleIdList><ArticleId IdType="doi">10.14218/JCTH.2014.00032</ArticleId><ArticleId IdType="pubmed">26357634</ArticleId><ArticleId IdType="pmc">4542083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanin-Silva DC, Santana-Goncalves M, Kawashima-Vasconcelos MY, Oliveira MC (2021) Management of endothelial dysfunction in systemic sclerosis: current and developing strategies. Front Med 8:788250. https://doi.org/10.3389/fmed.2021.788250</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.788250</ArticleId></ArticleIdList></Reference><Reference><Citation>Akca UK, Batu ED, Kisaarslan AP, Poyrazoglu H, Ayaz NA, Sozeri B, Sag E, Atalay E, Demir S, Karadag SG, Demir F, Bilginer Y, Gumruk F, Ozen S (2021) Hematological involvement in pediatric systemic lupus erythematosus: a multicenter study. Lupus 30:1983&#x2013;1990. https://doi.org/10.1177/09612033211038824</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211038824</ArticleId><ArticleId IdType="pubmed">34459313</ArticleId></ArticleIdList></Reference><Reference><Citation>Batu ED, Akca UK, Kisaarslan AP, Sag E, Demir F, Demir S, Cicek SO, Poyrazoglu H, Sozeri B, Bilginer Y, Ozen S (2021) The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic Lupus Erythematosus. J Rheumatol 48:907&#x2013;914. https://doi.org/10.3899/jrheum.200871</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.200871</ArticleId><ArticleId IdType="pubmed">33191281</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorkem SB, Doria AS, Tse S (2019) Imaging findings of mixed connective tissue disease in children and adolescents: a case series. Jpn J Radiol 37:371&#x2013;379. https://doi.org/10.1007/s11604-019-00824-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11604-019-00824-4</ArticleId><ArticleId IdType="pubmed">30875012</ArticleId></ArticleIdList></Reference><Reference><Citation>Singsen BH, Bernstein BH, Kornreich HK, King KK, Hanson V, Tan EM (1977) Mixed connective tissue disease in childhood. A clinical and serologic survey. J Pediatr 90:893&#x2013;900. https://doi.org/10.1016/s0022-3476(77)80555-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(77)80555-6</ArticleId><ArticleId IdType="pubmed">300795</ArticleId></ArticleIdList></Reference><Reference><Citation>Singsen BH, Swanson VL, Bernstein BH, Heuser ET, Hanson V, Landing BH (1980) A histologic evaluation of mixed connective tissue disease in childhood. Am J Med 68:710&#x2013;717. https://doi.org/10.1016/0002-9343(80)90258-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(80)90258-2</ArticleId><ArticleId IdType="pubmed">6966469</ArticleId></ArticleIdList></Reference><Reference><Citation>Alduraibi F, Fatima H, Hamilton JA, Chatham WW, Hsu HC, Mountz JD (2022) Lupus nephritis correlates with B cell interferon-beta, anti-Smith, and anti-DNA: a retrospective study. Arthritis Res Ther 24:87. https://doi.org/10.1186/s13075-022-02766-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-022-02766-1</ArticleId><ArticleId IdType="pubmed">35436902</ArticleId><ArticleId IdType="pmc">9014622</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevez Del Toro M, Varela Ceballos I, Chico Capote A, Kokuina E, Sanchez Bruzon Y, Casas Figueredo N (2022) Predictive factors for the development of lupus nephritis after diagnosis of systemic lupus erythematosus. Reumatol Clin 18:513&#x2013;517. https://doi.org/10.1016/j.reumae.2021.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reumae.2021.08.003</ArticleId><ArticleId IdType="pubmed">35523640</ArticleId></ArticleIdList></Reference><Reference><Citation>Tellier S, Bader-Meunier B, Quartier P, Belot A, Deslandre C, Kone-Paut I, Tiriau S, Jurquet AL, Rosellini D, Dheu-Bentz C, Mestrallet G, Decramer S (2016) Initial presentation and outcome of pediatric-onset mixed connective tissue disease: a French multicenter retrospective study. Joint Bone Spine 83:369&#x2013;371. https://doi.org/10.1016/j.jbspin.2015.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2015.05.013</ArticleId><ArticleId IdType="pubmed">26677987</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>